Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors

por Gupta, Sachin, Termini, James M., Issac, Biju, Guirado, Elizabeth, Stone, Geoffrey W.
Publicado 2016

Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity

por Termini, James M., Martinez-Navio, José M., Gao, Guangping, Fuchs, Sebastian P., Desrosiers, Ronald C.
Publicado 2020

HEK293T cell lines defective for O-linked glycosylation

por Termini, James M., Silver, Zachary A., Connor, Bryony, Antonopoulos, Aristotelis, Haslam, Stuart M., Dell, Anne, Desrosiers, Ronald C.
Publicado 2017

Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines

por Gupta, Sachin, Termini, James M, Niu, Liguo, Kanagavelu, Saravana K, Rahmberg, Andrew R, Kornbluth, Richard S, Evans, David T, Stone, Geoffrey W
Publicado 2011

Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion

por Termini, James M., Gupta, Sachin, Raffa, Francesca N., Guirado, Elizabeth, Fischl, Margaret A., Niu, Liguo, Kanagavelu, Saravana, Stone, Geoffrey W.
Publicado 2017

HIV-1 Adenoviral Vector Vaccines Expressing Multi-Trimeric BAFF and 4-1BBL Enhance T Cell Mediated Anti-Viral Immunity

por Kanagavelu, Saravana, Termini, James M., Gupta, Sachin, Raffa, Francesca N., Fuller, Katherine A., Rivas, Yaelis, Philip, Sakhi, Kornbluth, Richard S., Stone, Geoffrey W.
Publicado 2014